ORBIMED ADVISORS LLC - 03 Nov 2025 SCHEDULE 13D/A Report for Terns Pharmaceuticals, Inc. Common Stock (TERN)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Terns Pharmaceuticals, Inc. Common Stock
Symbol
TERN
Shares outstanding
88,334,750 shares
Disclosed Ownership
4,240,068 shares
Ownership
4.8%
Form type
SCHEDULE 13D/A
Filing time
05 Nov 2025, 16:13:10 UTC
Date of event
03 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 4.8% ownership in Terns Pharmaceuticals, Inc. Common Stock (TERN) on 03 Nov 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Terns Pharmaceuticals, Inc. Common Stock (TERN).
  • Disclosed ownership: 4.8%.
  • Date of event: 03 Nov 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Nov 2025, 16:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 4.8% 4,240,068 0 4,240,068 /s/ Carl L. Gordon Carl L. Gordon / Member 0001055951
ORBIMED CAPITAL GP VII LLC 3.1% 2,722,283 0 2,722,283 /s/ Carl L. Gordon Carl L. Gordon / Member of OrbiMed Advisors LLC 0001760648
OrbiMed Asia GP III, L.P. 1.2% 1,061,075 0 1,061,075 /s/ Carl L. Gordon Carl L. Gordon / Director of OrbiMed Advisors III Limited 0001841462
OrbiMed Advisors III Ltd 1.2% 1,061,075 0 1,061,075 /s/ Carl L. Gordon Carl L. Gordon / Director 0001841537
OrbiMed Genesis GP LLC 0.5% 456,710 0 456,710 /s/ Carl L. Gordon Carl L. Gordon / Member of OrbiMed Advisors LLC 0001808744

Sponsored